相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Genetic epidemiology and pharmacogenetics in irritable bowel syndrome
Michael Camilleri et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2012)
Pharmacogenetic Trial of a Cannabinoid Agonist Shows Reduced Fasting Colonic Motility in Patients With Nonconstipated Irritable Bowel Syndrome
Banny S. Wong et al.
GASTROENTEROLOGY (2011)
Cannabinoid Receptor 1 Gene Polymorphism and Irritable Bowel Syndrome in the Korean Population A Hypothesis-generating Study
Jae Myung Park et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2011)
Epidemiology of irritable bowel syndrome in Asia: Something old, something new, something borrowed
Kok-Ann Gwee et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2009)
Genetic variation in endocannabinoid metabolism, gastrointestinal motility, and sensation
Michael Camilleri et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2008)
The association of serotonin transporter genetic polymorphisms and irritable bowel syndrome and its influence on tegaserod treatment in chinese patients
Yuyuan Li et al.
DIGESTIVE DISEASES AND SCIENCES (2007)
Effects of a cannabinoid receptor agonist on colonic motor and sensory functions in humans: a randomized, placebo-controlled study
Tuba Esfandyari et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2007)
Nutrient-dependent enhancement of rectal sensitivity in irritable bowel syndrome (IBS)
M. Simren et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2007)
Involvement of cannabinoid receptors in inflammatory hypersensitivity to colonic distension in rats
M. Sanson et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2006)
(AAT)n repeat in the cannabinoid receptor gene, CNR1:: association with schizophrenia in a Spanish population
Isabel Martinez-Gras et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2006)
Cannabinoid 1 (CB1) receptors coupled to cholinergic motorneurones inhibit neurogenic circular muscle contractility in the human colon
Nicholas M. Hinds et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
(AAT)n repeat in the cannabinoid receptor gene (CNR1):: association with cocaine addiction in an African-Caribbean population
N Ballon et al.
PHARMACOGENOMICS JOURNAL (2006)
The endocannabinoid system as an emerging target of pharmacotherapy
Pal Pacher et al.
PHARMACOLOGICAL REVIEWS (2006)
The genetics of irritable bowel syndrome
YA Saito et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2005)
Cannabinoid-based drugs as anti-inflammatory therapeutics
TW Klein
NATURE REVIEWS IMMUNOLOGY (2005)
Depression in Parkinson's disease is related to a genetic polymorphism of the cannabinoid receptor gene (CNR1)
FJ Barrero et al.
PHARMACOGENOMICS JOURNAL (2005)
Reduced cellular expression and activity of the P129T mutant of human fatty acid amide hydrolase: evidence for a link between defects in the endocannabinoid system and problem drug use
KP Chiang et al.
HUMAN MOLECULAR GENETICS (2004)
Human cannabinoid receptor 1:: 5′ exons, candidate regulatory regions, polymorphisms, haplotypes and association with polysubstance abuse
PW Zhang et al.
MOLECULAR PSYCHIATRY (2004)
Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system
BF Cravatt et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2003)
Abnormal colonic propagated activity in patients with slow transit constipation and constipation-predominant irritable bowel syndrome
G Bassotti et al.
DIGESTION (2003)
Brain monoglyceride lipase participating in endocannabinoid inactivation
TP Dinh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Endocannabinoids as physiological regulators of colonic propulsion in mice
L Pinto et al.
GASTROENTEROLOGY (2002)
A missense mutation in human fatty acid amide hydrolase associated with problem drug use
JC Sipe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
The menstrual cycle affects rectal sensitivity in patients with irritable bowel syndrome but not healthy volunteers
LA Houghton et al.
GUT (2002)
CNR1, central cannabinoid receptor gene, associated with susceptibility to hebephrenic schizophrenia
H Ujike et al.
MOLECULAR PSYCHIATRY (2002)
Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase
BF Cravatt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Impaired transit and tolerance of intestinal gas in the irritable bowel syndrome
J Serra et al.
GUT (2001)
Localization of CB1-cannabinoid receptor immunoreactivity in the porcine enteric nervous system
A Kulkarni-Narla et al.
CELL AND TISSUE RESEARCH (2000)
Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial
M Camilleri et al.
LANCET (2000)
Association study of a cannabinoid receptor gene (CNR1) polymorphism and schizophrenia
SJ Tsai et al.
PSYCHIATRIC GENETICS (2000)
分享论文
